Patents Assigned to Active Motif, Inc.
  • Patent number: 12049622
    Abstract: Disclosed herein are compositions, methods and kits useful for epigenetic analysis based on the use of transposons that are targeted to specific regions of chromatin based on DNA-DNA interactions, protein-protein interactions, RNA-RNA interactions, and nucleic acid-protein interactions.
    Type: Grant
    Filed: March 25, 2022
    Date of Patent: July 30, 2024
    Assignee: ACTIVE MOTIF, INC.
    Inventors: Mary Anne Jelinek, Brian Stanley Egan, Joseph Fernandez
  • Publication number: 20220162675
    Abstract: Provided herein are methods for mapping modified nucleotide residues in nucleic acids. The methods include providing a nucleic acid sample in which non-target or target modified and unmodified nucleotide residues are converted to form of a different nucleotide (such a “C” being converted to “T”). Second strand synthesis is then performed on the converted nucleic acids using a set of anchored-base primers. Each primer in the set of anchored-base primers comprises one or more anchor bases at the 3? terminus that are complementary to the target nucleotide (e.g., “G” or “CpG”), and a sequence of nucleotides selected from a set of sequences that could be a fully or partially degenerate set of sequences. For example, the sequence could be 5?-XnG-3? and/or 5?-X(n?1)CG-3?, wherein X is any base, and n=2 to 25. Double-stranded nucleic acid products can be analyzed, for example by amplification and high throughput sequencing.
    Type: Application
    Filed: December 23, 2020
    Publication date: May 26, 2022
    Applicants: Active Motif, Inc., Active Motif, Inc.
    Inventors: Benjamin F. DELATTE, Eddie W. ADAMS, Joseph M FERNANDEZ
  • Patent number: 11306307
    Abstract: Disclosed herein are compositions, methods and kits useful for epigenetic analysis based on the use of transposons that are targeted to specific regions of chromatin based on DNA-DNA interactions, protein-protein interactions, RNA-RNA interactions, and nucleic acid-protein interactions.
    Type: Grant
    Filed: June 4, 2020
    Date of Patent: April 19, 2022
    Assignee: ACTIVE MOTIF, INC.
    Inventors: Mary Anne Jelinek, Brian Stanley Egan, Joseph Fernandez
  • Publication number: 20200299678
    Abstract: Disclosed herein are compositions, methods and kits useful for epigenetic analysis based on the use of transposons that are targeted to specific regions of chromatin based on DNA-DNA interactions, protein-protein interactions, RNA-RNA interactions, and nucleic acid-protein interactions.
    Type: Application
    Filed: June 4, 2020
    Publication date: September 24, 2020
    Applicant: Active Motif, Inc.
    Inventors: Mary Anne JELINEK, Brian Stanley EGAN, Joseph FERNANDEZ
  • Patent number: 10689643
    Abstract: Disclosed herein are compositions, methods and kits useful for epigenetic analysis based on the use of transposons that are targeted to specific regions of chromatin based on DNA-DNA interactions, protein-protein interactions, RNA-RNA interactions, and nucleic acid-protein interactions.
    Type: Grant
    Filed: May 22, 2014
    Date of Patent: June 23, 2020
    Assignee: ACTIVE MOTIF, INC.
    Inventors: Mary Anne Jelinek, Brian Stanley Egan, Joseph Fernandez
  • Patent number: 10663455
    Abstract: This invention provides transcription regulatory control sequences, the activity of which function as biomarkers for a variety of biological responses. This invention also provides expression constructs in which a biomarker transcription regulatory sequence is operably linked with a sequence for a reporter. Cells that comprise these expression constructs can be used in assays to identify conditions that modulate activity of the biological response.
    Type: Grant
    Filed: March 13, 2017
    Date of Patent: May 26, 2020
    Assignee: ACTIVE MOTIF, INC.
    Inventors: Shelley Force Aldred, Nathan D. Trinklein, Michael Rose, Patrick Collins
  • Patent number: 9938524
    Abstract: The invention provides novel methods and materials for genetic and genomic analysis using single or multiplex isolation of protein-associated nucleic acids, including transposase-assisted chromatin immunoprecipitation (TAM-ChIP) and antibody-oligonucleotide proximity ligation. These methods comprise tagging and isolating chromatin or other protein-associated nucleic acids and using antibody-oligonucleotide complexes that recognize the proteins associated with such nucleic acids.
    Type: Grant
    Filed: November 23, 2012
    Date of Patent: April 10, 2018
    Assignee: Active Motif, Inc.
    Inventors: Joseph Fernandez, Mary Anne Jelinek, Brian Stanley Egan
  • Publication number: 20180010121
    Abstract: Disclosed herein are compositions, methods and kits useful for epigenetic analysis based on the use of transposons that are targeted to specific regions of chromatin based on DNA-DNA interactions, protein-protein interactions, RNA-RNA interactions, and nucleic acid-protein interactions.
    Type: Application
    Filed: May 22, 2014
    Publication date: January 11, 2018
    Applicant: Active Motif, Inc.
    Inventors: Mary Anne Jelinek, Brian Stanley Egan, Joseph Fernandez
  • Publication number: 20160115474
    Abstract: Disclosed herein are compositions, methods and kits useful for epigenetic analysis based on the use of transposons that are targeted to specific regions of chromatin based on DNA-DNA interactions, protein-protein interactions, RNA-RNA interactions, and nucleic acid-protein interactions.
    Type: Application
    Filed: May 22, 2014
    Publication date: April 28, 2016
    Applicant: Active Motif, Inc.
    Inventors: Mary Anne Jelinek, Brian Stanley Egan, Joseph Fernandez